Adélaïde Savoy

Adélaïde Savoy

Auto-generated profile, based on publicly available information

Adélaïde Savoy

Laboratorium für Organische Chemie Department of Chemistry and Applied Biosciences ETH Zürich Vladimir‐Prelog‐Weg 2 Zürich 8093 Switzerland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2025 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
VGVladimir Gorbachev
Vladimir Gorbachev
ASAdélaïde Savoy
Adélaïde Savoy
ATAlexandra Tsybizova
Alexandra Tsybizova
RPRobert Pollice
Robert Pollice
LTLara van Tetering
Lara van Tetering
PCPeter Chen
Peter Chen

23 October 2025 in Chemistry – A European Journal
Verified
Journal Article
Open access
ASAdélaïde Savoy
Adélaïde Savoy
VGVladimir Gorbachev
Vladimir Gorbachev
CSCharlotte N. Stindt
Charlotte N. Stindt
PCPeter Chen
Peter Chen
We report a systematic investigation of noncovalent interactions—particularly an intramolecular hydrogen bond and London Dispersion forces—in singly protonated bis‐pyridines, studied across solution and crystalline states. Building on our previous gas‐phase study, we combine variable‐temperature 1 H NMR spectroscopy, single‐crystal X‐ray diffraction, and density functional theory (DFT) calculations. The measured 1 H NMR chemical shifts of the acidic proton serve as a solution‐phase structural readout, which we correlate with an independent crystallographic metric. By systematically varying the linker (–CH 2 –, –O–, and –CH 2 CH 2 –) and the pendant substituents (H, methyl, tert ‐butyl), we examine how increasingly bulky “dispersion energy donors” affect both the intramolecular hydrogen bond and the accessible conformational states. In reference systems, where a single noncovalent interaction governs the geometry, even relatively simple computational models correctly reproduce the experimentally observed structures. However, for molecules featuring two competing noncovalent interactions, the tested, dispersion‐corrected, DFT often fails to predict the relative energies of accessible conformers accurately, highlighting current limitations in predictive accuracy. We briefly discuss broader implications of currently achievable predictive accuracy for homogeneous catalysis.

23 September 2026 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
ASAdélaïde Savoy
Adélaïde Savoy
PGPia Götz
Pia Götz
MKMartin Kuentz
Martin Kuentz

1 September 2026 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
HKHari P. Kandagatla
Hari P. Kandagatla
NCNower Chowdhury
Nower Chowdhury
TVTatjana Ž. Verbić
Tatjana Ž. Verbić
AAAlex Avdeef
Alex Avdeef
ASAdélaïde Savoy
Adélaïde Savoy
ASAbu T. M. Serajuddin
Abu T. M. Serajuddin

30 June 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
HKHari P. Kandagatla
Hari P. Kandagatla
NCNower Chowdary
Nower Chowdary
TVTatjana Verbić
Tatjana Verbić
ASAdélaïde Savoy
Adélaïde Savoy
MKMartin Kuentz
Martin Kuentz
ASAbu T. M. Serajuddin
Abu T. M. Serajuddin
Although lipid-based formulations (LBFs) of self-emulsifying drug delivery systems (SEDDS) have been used for poorly water-soluble drugs, they have many limitations, the first being the low solubility of drugs in lipids, which limits drug loading in formulations, and the second being inadequate dispersion of formulations in the aqueous fluids of the human gastrointestinal tract (GIT). Large amounts of organic cosolvents and surfactants, up to 90% of the formulation, have been used to overcome these limitations. We previously demonstrated that the situation could be improved by using lipid digestion products (LDP), which consist of a 2:1 molar ratio of long-chain fatty acids and monoglycerides, rather than lipids (triglycerides) themselves. The drug solubility and, therefore, drug loading in the formulations increased greatly due to the presence of long-chain fatty acid in the LDP. However, only oleic acid (OA)and its monoglyceride were used in those studies. To demonstrate the versatility of the approach, mixtures of linoleic acid (LA) and glyceryl monolinoleate (GML) at a 2:1 molar ratio were used in the present study, with clofazimine (CFZ) as the model drug. Although both OA and LA are long-chain fatty acids with 18 carbon atoms, the latter has two double bonds instead of one, and it was hypothesized that an extra double bond could improve the microemulsification of the LBF, reduce particle size after emulsification in aqueous media, and enhance drug absorption in vivo. LA showed a high CFZ solubility of 480 mg/g, comparable to OA; however, it performed better in LBFs, with the developed formulation (100 mg/g) dispersing as less than 250 nm size microemulsions at intestinal pH, compared to 400 nm for OA.